A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys-Reference-Cited by-同舟云学术

A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys

Published:2017-01-26 Issue:5 Volume:158 Page:1314-1327
ISSN:0013-7227
Container-title:Endocrinology
language:en
Short-container-title:

Author:

Stanislaus Shanaka,Hecht Randy,Yie Junming,Hager Todd,Hall Michael,Spahr Chris,Wang Wei,Weiszmann Jennifer,Li Yang,Deng Liying,Winters Dwight,Smith Stephen,Zhou Lei,Li Yuesheng,Véniant Murielle M.,Xu Jing

Publisher

The Endocrine Society

Subject

Endocrinology

Link

http://academic.oup.com/endo/article-pdf/158/5/1314/14069029/en.2016-1917.pdf

Reference31 articles.

1. Update on the treatment of type 2 diabetes mellitus;World J Diabetes,2016

2. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes;Professional Practice Committee, American Diabetes Association;Diabetologia,2006

3. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies;Lancet,2008

4. Inventing new medicines: the FGF21 story;Mol Metab,2013

5. FGF-21 as a novel metabolic regulator;J Clin Invest,2005

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computer-aided engineering of stabilized fibroblast growth factor 21;Computational and Structural Biotechnology Journal;2024-12

2. The hepatokine FGF21 stopped lipogenesis and reduced testosterone production in mLTC-1 Leydig Cell Line;Molecular and Cellular Endocrinology;2024-12

3. FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond;Journal of Hepatology;2024-09

4. Development of Zalfermin, a Long-Acting Proteolytically Stabilized FGF21 Analog;Journal of Medicinal Chemistry;2024-07-16

5. Defective FGFR1 Signaling Disrupts Glucose Regulation: Evidence From Humans With FGFR1 Mutations;Journal of the Endocrine Society;2024-06-13